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Abstract
Over the last few years, array-CGH has remarkably improved the ability to detect cryptic unbalanced rearrangements in patients
presenting with syndromic mental retardation. Using whole genome oligonucleotide array-CGH, we detected 5q14.3 microdeletions
ranging from 216 kb to 8.8 Mb in 5 unrelated patients showing phenotypic similarities, namely severe mental retardation with absent
speech, hypotonia and stereotypic movements. Most of the patients presented also with facial dysmorphic features, epilepsy and/or
cerebral malformations. The minimal common deleted region of these 5q14 microdeletions encompassed only known to actMEF2C, 
in brain as a neurogenesis effector which regulates excitatory synapse number. In a patient presenting a similar phenotype, we
subsequently identified a nonsense mutation. Taken together, these results strongly suggest that haploinsufficiency of MEF2C 
is responsible for severe mental retardation with stereotypic movements, seizures and/or cerebral malformations.MEF2C 
MESH Keywords Cerebrum ; abnormalities ; metabolism ; Child ; Child, Preschool ; Chromosome Deletion ; Chromosomes, Human, Pair 5 ; genetics ; Epilepsy ; genetics 
; Haploidy ; Humans ; Infant ; MADS Domain Proteins ; genetics ; Mental Retardation ; genetics ; Myogenic Regulatory Factors ; genetics ; Stereotypic Movement Disorder ; 
genetics
Author Keywords 5q14.3 microdeletion ; mental retardation ; array-CGH ; MEF2C ; seizures
INTRODUCTION
The clinical implementation of whole genome array comparative genomic hybridization (array-CGH) has revolutionised the diagnosis
of patients with mental retardation, congenital anomalies or neuropsychiatric disorders. With high-density microarrays, presence of
chromosome imbalances is detected in up to 17  of idiopathic developmental delay-mental retardation. On the basis of array-CGH data,% 1 
new microdeletion and microduplication syndromes have been described such as the 17q21.31 microdeletion involving the geneMAPT 
and resulting in syndromic mental retardation with typical facial features, the 15q13.3 microdeletion associated with mental retardation2 
and seizures and the 1q21.1 microdeletion, between BP2-BP3 regions, involving the gene in TAR syndrome. Array-CGH also3 PIAS3 4 
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lead to the identification of several genes involved in monogenic disorders, such as in CHARGE and in Pitt-HopkinsCHD7 TCF4 
syndrome.5 –7
Recently, Cardoso reported 3 cases of 5q14.3-q15 deletions presenting with severe mental retardation, hypotonia, seizures,et al 8 
minor dysmorphic features and periventricular heterotopia and an additional case has been reported in the Decipher database
(https://decipher.sanger.ac.uk/application/). Here, we report the detection of five distinct 5q14 deletions in 5 unrelated patients presenting
with severe mental retardation, absent speech and stereotypic movements and one duplication of the 5q14 region in a patient with mental
retardation. These deletions, which are different to those reported by Cardoso et al , allowed us to define a minimal critical region8 
encompassing only the gene and led us to sequence this gene in patients with similar phenotypes. We provide argumentsMEF2C 
indicating that this severe mental retardation results from haploinsufficiency.MEF2C 
PATIENTS AND METHODS
Patients
All 7 patients included in this study have been examined by a clinical geneticist in the context of etiologic investigations in children
affected with developmental delay. Array-CGH analysis was performed since mental retardation was associated with at least two of the
following criteria, dysmorphic facial features, family history of mental retardation, growth anomaly or congenital malformation. Fori.e. 
the 7 patients, high resolution chromosome analysis and extensive biochemical metabolic screening (lactic acid, pyruvic acid, ammoniac,
plasmatic amino acids and urine organic acids analyses, purine metabolism, blood and urinary creatine and guanido-acetic acid) were
normal. For each patient, blood samples for genetic analyses were collected after having obtained written informed consent of the parents.
Clinical presentations of the patients are summarized in .Table 1 
Case 1
BV is the third child of healthy unrelated parents. She was born at 36 week s gestation (WG) with normal growth parameters. At 3’
days of age, she experienced a single episode of cyanosis with eye revulsion. Frequent crying, sleep disturbance, hypotonia and poor visual
contact were noted at 3 months. From the age of 4 months, myoclonic jerks of the upper limbs were noted and followed, several weeks
later, by brief episodes of eye revulsion concomitant with the jerks. Epilepsy was diagnosed at the age of 7 months and characterized by
the association of several bilateral isolated spasms and frequent synchronous myoclonus with abnormal and slow background EEG pattern.
Clinical examination at 4 years 9 months showed normal growth and head circumference. Developmental delay was severe. She sat
unaided and was able to crawl manipulate toys. Eye contact was present though transient. Speech was absent. She had stereotypic
repetitive movements, rocking her head and rubbing her chin with her hands. Subtelomeric rearrangements were excluded by QMPSF
(Quantitative Multiplex PCR of Short Fluorescent Fragments). Analysis of the gene revealed no alteration.CDKL5 
Case 2
CA is the second child of healthy unrelated parents. At birth, at 40 WG, weight and length were normal but head circumference was
along the 3 standard deviation (SD). Since the first day of life, she developed tonico-clonic seizures. EEG revealed frequent bursts with−
no basic rhythm and a very unstructured pattern. At 9 months of age, severe hypotonia and poor eye contact were noted. Awakening stages
were short. Despite treatment, the seizures occurred every day.
Case 3
ED is the second child of healthy unrelated parents. Delivery was provoked at 41 WG because of abnormal foetal cardiac rhythm. A
birth, weight and length were on 3 SD but head circumference was small ( 2.5 SD). At the age of 2 months, severe hypotonia and absent+ −
eye contact were noted. Cortical blindness was subsequently diagnosed. EEG showed a slow basic rhythm with infraclinical
temporoparietal paroxystic discharges. At 18 months of age, weight gain was insufficient ( 2 SD) leading to a gastrostomy tube−
placement. He presented severe hypotonia, transient eye contact and sleep disturbance.
Case 4
WD is the second child of healthy unrelated parents. Delivery occurred at 38 WG and birth growth parameters were within the normal
range. Failure to thrive and severe hypotonia were observed and led to several neurological investigations at the age of 4 months. Eye
contact was difficult to obtain during the first year of life. He never experienced seizures. EEG was normal. He sat unaided at age 18
months and crawled at age 2 years. When referred to the genetic clinic at 3 years of age, he was able to stand, cruise along the furniture
and manipulate toys. Speech was absent. Eye contact was transient. He presented with repetitive hand flapping and clapping movements.
Diagnosis of Angelman syndrome was considered to be unlikely on the basis of a normal methylation pattern.SNRPN 
Case 5
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LD is the second child of healthy parents who were first cousins. She was born at 40WG, with growth parameters below 2SD.−
Hypotonia and developmental delay were observed during the first months of life. At 3 years of age, she experienced tonico-clonic febrile
seizures which were well controlled by valproate. At 7 years, she was unable to walk and had not acquired any language skill. She had
repetitive hand washing and hand-to-mouth movements as well as frequent bouts of hyperventilation. Subtelomeric rearrangements were
excluded by FISH. Screening of the gene revealed no deleterious mutation.MECP2 
Case 6
TM is the third child of healthy unrelated parents. Growth parameters at birth on term were in the normal range. He was first referred
at the age of 2 years 6 months for a mild global developmental delay. He was able to walk unaided since the age of 2 years. Cerebral MRI
and EEG were normal. Clinical examination at 6 years of age revealed a microcephaly ( 3 SD) with normal height and weight. He−
presented mental retardation: IQ was evaluated between 50 and 60 (WISC IV). Speech was severely delayed but understandable; he was
not able to pronounce short sentences. Eye contact, behaviour, and social skills were normal. Special education was required. Subtelomeric
rearrangements and the most frequent microdeletion syndromes were excluded using the MLPA (Multiplex Ligation-dependent Probe
Amplification) method.
Case 7
DG is the first girl born to healthy non-consanguineous parents with an unremarkable family history. She was born on term after an
uneventful pregnancy. At birth, growth parameters were normal. The neonatal period was normal apart from difficulties in breastfeeding.
She appeared to develop normally until the age of 5 months. From the age of 5 months, she started to regress and to lose previously
acquired skills. She was unable to use her hands purposefully and failed to acquire vocalization with intonation. She walked unaided at age
3 years. She presented behavioral disorders, including decreased eye contact, lack of emotional reciprocity, lack of interest in her
surroundings and hand and hand-mouth stereotypic movements. She also had severe feeding difficulties that started at age 5 months and
were still present at 7 years of age. Generalized tonico-clonic seizures, well controlled on sodium valproate, started at age 9 months. At 7
years of age, she was severely mentally impaired and presented with poor eye contact and no speech. Neurological examination showed an
unstable, wide-based gait, without any objective cerebellar signs. Sequencing of the and genes revealed no mutation.MECP2 CDKL5 
Standard and molecular karyotyping
Karyotyping of RHG-banded chromosomes from lymphocytes at 550-band resolution was performed according to standard
procedures. High molecular weight genomic DNA was extracted from patient s peripheral blood lymphocytes using the QIAamp DNA’
Blood Midi kit (Qiagen, Valencia, CA, USA) according to the manufacturer s instructions. DNA concentration was determined with’
NanoDrop ND-1000 spectrophotometer and software (NanoDrop Technologies, Berlin, Germany). Detection of gene copy number was
performed by array- CGH following standard and manufacturer s recommendations (Agilent, Agilent Technologies, Santa Clara, CA,’
USA) using 44 000 oligo probes approximately spaced at 35 40 kb intervals across the genome (Human Genome CGH microarray 44B–
kit, Agilent) or 244 000 oligo probes approximately spaced at 10 kb intervals across the genome (Human Genome CGH microarray 244B
kit, Agilent). Commercial (Promega, Madison, WI, USA) or non commercial female and male genomic DNA were used as references.
Hybridization results were extracted with Feature extraction software and analyzed with the DNA-analytics software by applying a Z-score
or ADM 2 segmentation algorithm to identify chromosome aberrations. Copy-number gains and losses were determined by threshold of
0.3 and 0.3, respectively. Aberrant signals obtained with three or more neighbouring oligonucleotides were considered indicative of−
genomic aberrations and further evaluated by FISH, MP-LC, qPCR and/or QMPSF, unless they coincided with a published DNA
copy-number variant, as listed in the Database of Genomic Variants ( , version June 2008).http://projects.tcag.ca/variation/?source=hg18 
FISH analysis
Aberrations were validated by Fluorescence hybridization (FISH) experiments (see supplementary data). FISH was performedin situ 
with RP11-1006G2 (case 1), with RP11-1147F22 (case 2 and case 3), with CTD-2328P23, RP11-1147F22 and RP11-110I3 (case 5) and
with CTD-2328P23 (case 6).
QMPSF (Quantitative Multiplex PCR of Short Fluorescent Fragments)
exon 2 was PCR-amplified using the dye-labeled primers MEF2C-F (5MEF2C ′
-CGTTAGATAGTGGGAACTGAGCTGTGCAAGT-3 ) and MEF2C-R (5 -GATAGGGTTACGTTCATCCATAATCCTCGTAATC-3) .′ ′ ’
Exon 13 of located on chromosome 11 and exon 4 of located on chromosome Xq28, were co-amplified as controls, usingHMBS MECP2 
the dye-labeled primers HMBS-F (5 -CGTTAGATAGACGGCTCAGATAGCATACAAG-3 ); and HMBS-R (5′ ′ ′
-GATAGGGTTAATGCCTACCAACTGTGGGTCA-3 ); MECP2-F (5 -CGTTAGATAGTTTCGCTCTAAAGTGGAGTTGAT-3 ) and′ ′ ′
MECP2-R (5 -GATAGGGTTAGGGCTTCTTAGGTGGTTTCTG-3 ), respectively. Detailed description of the QMPSF analyses is′ ′
available in supplementary data.
MEF2C haploinsufficiency
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Multiplex PCR/Liquid Chromatography (MP-LC)
intron 2 was PCR-amplified using the following primers: MEF2C-MPLC-F (5 -TAATCCAGGAGCCACAGGTC-3 ) andMEF2C ′ ′
MEF2C-MPLC-R (5 -GAGAAAGAGCATTTAGGAGGG-3 ). An additional fragment, corresponding to the gene located on′ ′ HMBS 
chromosome 11, was co-amplified as control (primers are available on request). Detailed description of the MP-LC analyses is available in
supplementary data.
Quantitative PCR
Quantitative PCR (qPCR) of was performed using SYBR green (see supplementary data). The gene, was used forMEF2C RPPH1 
normalisation. MEF2C exon 1 was amplified with the primer MEF2C-E1-F (5 -TGTCAGGGTTTGGACAACAA-3 ) and MEF2C-E1-R (5′ ′
-TGGCAATTGAAACTCACCA-3 ) and exon 2 was amplified with MEF2C-E2-F (5 -CACATTTGAAGGTGCCAAAG-3 ) and′ ′ MEF2C ′ ′
MEF2C-E2-R (5 -CAATCATTTGCCTTCCGTTC-3 ).′ ′
Sequencing analysis of the geneMEF2C 
The 10 coding exons of the gene, including the exon-intron junctions, were PCR-amplified (primers are available on request)MEF2C 
from 100 ng of genomic DNA in 50 l containing 1.5 mM MgCb, 75 mM Tris-HCl (pH 9 at 25 C), 20 mM (NH4) SO , 0.01  Tween 20,μ ° 2 4 %
50 pmol of each primer, 200 M of each dNTP and 2 units of Hot GoldStar (Eurogentec, Seraing, Belgium). PCR conditions include oneμ
cycle for 4 min at 94 C followed by 30 cycles at 94 C for 30 s, 58 C for 30 s, 72 C for 1 min, and one last cycle at 72 C for 5 min. The° ° ° ° °
purified PCR products were then sequenced using a Ceq2000/8000 DNA sequencer (CEQ DTCS-Quick Start Kit, Beckman Coulter,
Fullerton, CA, USA).
RESULTS
In the course of systematic molecular karyotyping of patients with syndromic mental retardation, we identified five 5q14 deletions and
one 5q14 duplication. All patients with 5q14 deletion (cases 1 to 5, ) presented with early and severe developmental delay andTable 1 
hypotonia. Speech was absent in all cases. None of the children was able to walk unaided. Stereotypic movements were present in 3/5
patients and absent in the two youngest children. Different types of epilepsy were observed in 3/5 of our patients, from well controlled
generalized seizures to early refractory tonicoclonic or myoclonic epilepsy. Miscellaneous dysmorphic facial features were present in all
cases ( ), but some common features were noticed high and wide forehead, pronounced eyebrows, anteverted nostrils, short andfig. 1 i.e. 
prominent philtrum, down turned corners of the mouth and small chin. In 3/5 cases, palpebral fissures were up-slanted.
All patients with 5q14 deletion displayed MRI abnormalities ( ), including either corpus callosum agenesis (2/5) or increasedtable 1 
corpus callosum thickness and shortness (1/5), abnormal gyration (1/5), fronto-parietal atrophy and enlarged pericerebral spaces (1/5),
enlarged lateral ventricle (2/5) or enlarged fourth ventricle (2/5). As shown in and , the 5q14 deletions measured approximatelyfigures 2 3 
2.68 Mb (case 1), 3.5 Mb (case 2), 8.8 Mb (case 3), 1.57 Mb (case 4) and 216 Kb (case 5). In case 6, we detected a 5q14 duplication which
size was estimated to 4.6 Mb. These 5q14 rearrangements were all confirmed by a second independent method, i.e. QMPSF (case 1),
MP-LC (case 5 and 6), qPCR (case 4) and/or FISH analysis (case 1, 2, 3, 5 and 6) and segregation analyses revealed that they all had
occurred ( ). The smallest rearrangement detected in case 5, presenting a Rett-like phenotype with developmental delay, poorde novo fig. 4 
eye contact, epilepsy, stereotypic hand-mouth movements, episodes of hyperventilation and apnea, corresponded to a 216 Kb deletion
which encompassed a single gene, restricting therefore the minimal common deleted region to this gene.MEF2C, 
In cases 1, 2, 3 and 5, the deletion removed entirely the gene. In case 4, q-PCR showed a partial deletion of removingMEF2C MEF2C 
the first exon, the breakpoint being located within intron 1. These observations led us to perform sequencing analysis of the geneMEF2C 
in 5 additional patients affected with severe mental retardation, in whom the diagnosis of the Rett phenotype had been suggested and for
whom the array CGH array was normal. As shown in , in one patient (case 7), we identified a point mutation within exon 7fig. 4C 
(NM_002397.2:c.683C>G) predicted to result in a premature stop codon (p.Ser228X). Sequencing analysis performed in the parents
revealed that the mutation had occurred de novo.
DISCUSSION
We here report on five 5q14 submicroscopic deletions, one 5q14 duplication and one nonsense mutation in 7 unrelatedMEF2C 
children, all presenting with mental retardation.
The clinical significance of the 5q14.3 duplication remains uncertain and, despite its occurrence, it may represent a benignde novo 
variant. Such non-pathogenic duplications have been described, contrasting with the deleterious deletion mirror event. Alternatively, the8 
5q14.3 duplication may be responsible for a mild phenotype distinct from that resulting from the deletions. Indeed, 7q11.23, 16p 13.11 and
17p11.2 duplications result into relatively mild phenotype compared to deletions. Study of additional patients will be required to9 –11 
determine the pathogenic effect of the 5q14.3 duplication.
MEF2C haploinsufficiency
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In the five cases with 5q14.3 microdeletion, the developmental delay was severe, associating hypotonia, poor eye contact and
stereotypic hand movements (3/5). Moreover, in cases 4 and 5, classical Rett syndrome had initially been suspected because of repetitive
clapping hand-mouth movements. However, these two latter patients did not display any period of normal development or a progressive
loss of motor or communicative skills. Epilepsy was present in 3 cases. In one case, refractory myoclonic epilepsy with atypical spasms
beginning before 6 months of age, led us to consider initially the hypothesis of an early-onset seizures variant of Rett syndrome due to 
mutation. Nevertheless, the presence of dysmorphic facial features in all five cases was strongly suggestive of a chromosomalCDKL5 
aberration.
Only few interstitial 5q14 deletions detected by standard chromosomal analysis had previously been reported and were shown12 –18 
to be associated with severe to moderate mental retardation, growth retardation, deep hypotonia, facial dysmorphism and malformations.
The facial features included prominent forehead, epicanthal folds, brachycephaly, hypertelorism, flat nasal bridge, anteverted nostrils,
abnormal ears and short neck. Malformations were miscellaneous and included renal abnormalities, cleft palate, club feet, heart defect, and
dislocated hips. Among these cases, a clinical phenotype could hardly be delineated and epilepsy had not previously been reported.
Boundaries of the deletions in the different published cases are hardly comparable because of the low resolution level of chromosome
analyses.
The three 5q14.3-q15 deletion cases, recently reported by Cardoso , and an additional case reported in the Decipher databaseet al 8 
partially overlap with the 5q14.3 deletions that we report here. The critical regions, defined by the latter cases, are different. The common
clinical features presented both by these 4 previously described patients and the 5 cases described here include mental retardation, seizures
and dysmorphic facial features. Nevertheless, in contrast to the patients described by Cardoso , none of our cases presentedet al 8 
periventricular heterotopia. However, in our patients, a developmental defect of the neuronal migration with ectopic neurons cannot not be
formally excluded as a cause of the severe and early epilepsy associated with mental retardation.
In our patients, the 5q14 deletion sizes ranged from 216 Kb to 8.8 Mb. The absence of low copy repeat (LCR) sequences flanking the
breakpoints as well as the absence of recurrent breakpoints suggested that these rearrangements did not result from non-allelic homologous
recombination and involve another mechanism such as non homologous end joining of DNA breaks. The detection of a 216 Kb deletion,
removing only the gene, is a first argument supporting that haploinsufficiency of this gene contributes to the 5q14 microdeletionMEF2C 
syndrome. deletion is not a common CNV ( ) and the origin of the 5MEF2C http://projects.tcag.ca/variation/?source=hg18 de novo 
deletions reported in this study is in agreement with their causal role in the patient phenotypes. Although we cannot formally exclude that
haploinsufficiency of other 5q14 genes contribute to the phenotype of patients harbouring larger deletions, the fact that the 5 patients
reported in this study and presenting different deletion sizes showed striking phenotypic similarities ( ) strongly suggests that theTable 1 
phenotype is mainly due to deletion. Finally, the identification of an inactivation point mutation within gene in case 7MEF2C MEF2C 
constitutes a key argument demonstrating that haploinsufficiency of this gene results in mental retardation. The causal role of MEF2C 
alteration in the phenotype observed is in agreement with the biological function of the MEF2C protein and the murine models of MEF2C 
inactivation. Indeed, Myocyte Enhancer Factor 2 (MEF2) transcription factors act, in the brain, as effectors of neurogenesis which regulate
excitatory synapse number, dendrite morphogenesis and differentiation of post synaptic structures . The role of MEF2 proteins in19 20 
synaptic plasticity is consistent with a role in learning and memory. MEF2C is the predominant isoform in the developing cerebrocortex
and is highly expressed in frontal cortex, entorhinal cortex, cerebellum, dentate gyrus and amygdale. Conditional -null mice21 –22 Mef2c 
were generated as the knockout of the gene is embryonic lethal. , Late embryonic deletion of in the forebrain causesMef2c 23 24 Mef2c 
hippocampus-dependent learning and memory impairment associated to a dramatic increase in the number of excitatory synapses. The24 
role of Mef2c in synaptic plasticity in mice, limiting the excessive increase in the number of excitatory, is consistent with its possible
implication in seizures in human. In mutant mice with earlier embryonic deletion, abnormal aggregation and compaction of neurons
migrating into the lower layers of the neocortex during development were observed. As a consequence, the cortical plate in23 
postnatal/adult neocortex in these conditional -null mice displays disorganization and the neurons exhibit immatureMef2c 
electrophysiological properties characteristic of an immature neuronal network. These murine phenotypes provide convincing arguments
for the implication of haploinsufficiency as the cause of mental retardation observed in all cases and epilepsy in 4 of our cases.MEF2C 
Furthermore, the role of MEF2C in neuronal migration is of particular interest regarding to the periventricular heterotopia described by
Cardoso . Although was deleted in only one of their three cases, a position effect on of the two other deletionset al 8 MEF2C MEF2C 
cannot be excluded. This hypothesis is emphasized by the report, in a patient sharing a striking similar phenotype, of a balancedde novo 
translocation between chromosomes 5 and 8, the breakpoint being located just nearby the gene . Moreover, -null miceMEF2C 25 Mef2c 
display behavioural phenotypes with abnormal anxiety, decreased cognitive function, and marked paw wringing/clasping stereotypy,
resulting in a Rett-like phenotype as observed in mutant mouse models. , Additionally, according to the Transfac MatrixMecp2 23 24 
Database, the gene contains multiple putative MEF2 binding sites. Another gene, (deleted in autism-1 or ),Mecp2 DIA1 C3orf58 
containing putative MEF2 binding sites, has recently been implicated in autism and epilepsy. Indeed, a homozygous deletion of 27 DIA1 
was found in a case presenting with striking resemblances with deleted patients, i.e. early seizures, poor eye contact, absentMEF2C 
speech and stereotypic movements. Additional findings are needed to assess the role of MEF2C, DIA1 and MECP2 in a common
biological pathway essential for a normal neurological development.
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In conclusion, our results indicate that haploinsufficiency caused either by 5q14.3 microdeletion or by mutation is responsibleMEF2C 
for a severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
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Figure 1
Frontal and profile views of the 5 patients carrying 5q14 microdeletion or mutation. Note high and wide forehead, thick eyebrows,MEF2C 
short nose with anteverted nostrils, short and prominent philtrum, down turned corners of the mouth and small chin. (A) Case 1, note “
question mark ears  (constriction at the junction between the lower and the middle thirds of the pinna); (B) Case 2; (C) Case 3; (D) Case 4; (E)”
Case 5; (F) Case 7 harbouring the mutation.MEF2C 
Figure 2
Array-CGH profiles on chromosome 5 using Agilent 44K or 244K microarray (DNA analytics solftware display) showing the five
microdeletions and the microduplication. In case 1, 244K microarray shows that the proximal and distal breakpoint of the deletion are
respectively located between 86,939,816 and 87,005,072 and between 89,690,632 and 89,709,694. Using 44K microarrays, the proximal
breakpoints of the four other deletions and of the duplication were located between 87,770,283 and 88,051,970 in case 2, between 86,142,271
and 86,412,812 in case 3, between 88,185,407 and 88,268,343 in case 4, between 87,770,283 and 88,051,970 in case 5 and between
85,951,601 and 86,142,512 in case 6. Note that in patient 4, the proximal breakpoint has been localized by qPCR, between 88,221,326 and
88,235,476. The distal breakpoints of these rearrangements are respectively located between 91,578,247 and 91,730,827 in case 2, between
95,315,261 and 95,494,937 in case 3, between 89843194 and 89966438 in case 4, between 88,268.402 and 88,629.033 in case 5 and between
90,712,814 and 90,731,163 in case 6. The Human Gene Assembly used to define the extensions of the deletion is Hg18.
Figure 3
Schematic representation of the 5q14 genomic region. gene is indicated by black box. BAC clones appear above the genomicMEF2C 
representation and black bars. The minimal extents of deletions and of the duplication are respectively shown by grey boxes and a black box
below the chromosome scheme. The maximal extents of the region implicated are shown by dotted lines. Note that the smallest CNV detected
is a deletion of a single gene, , located from approximately 88,051,970 to 88,268,402 in hg 18 (in patient 5).MEF2C 
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Figure 4
Confirmation of the 5q14 deletion by QMPSF and FISH in case 1. (A) Electropherogram in case 1 (in red) was superimposed to that of a
normal female (in blue) by adjusting to the same level the peaks obtained for the and control amplicons. Case 1 is a female.HMBS MECP2 
The Y axis displays fluorescence in arbitrary units, and the X axis indicates the size in bp. Heterozygous 5q14 deletions are easily detected by
50  reduction of the peak in the patient compared to a normal control. (B) Results of two-colour FISH analysis in case 1 with% MEF2C 
RP11-1006G2 labelled with SpectrumGreen in combination with Cridu-chat syndrome probe used as control (5p15.2, Spectrum Green, 5q31
EGR1 Spectrum Orange, Abbott). Note that RP11-1006G2 is lacking on one chromosome 5 in the patient and is present on both homologous
chromosomes in the parents, demonstrating origin of the deletion. (C) Sequencing DNA chromatogram in case 7. Arrow indicates thede novo 
c.683 C>G mutation within exon 7 of .MEF2C 
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Table 1
Clinical findings in the 6 patients with deletions or mutationMEF2C 
Case 1 Case 2 Case 3 Case 4 Case 5 Case 7
Age at last examination 4 years 9 months 9 months 18 months 3 years 8 years 7 years
Birth weight/length/OFC 0 SD/0 SD/0 SD 0 SD/0 SD/ 3SD− +3 SD/ 3 SD/ 2.5 SD+ − −1 SD/ 1.5 SD/ 1 SD+ − −3SD/ 3SD/ 3SD− − 0 SD/0 SD/ 1.5 SD+
P o s t n a t a l
weight/height/OFC
−0.5 SD/ 0.5 SD/ 0.5 SD− − +2 SD/ 0.5 SD/ 2 SD− − −2 SD/0 SD/ 1 SD+ −1 SD/  1 SD/ 0.5 SD+ − −1SD/ 1 SD/ 1.5 SD− − 0 SD/0 SD/ 2 SD+
Hypotonia + + + + + −
Head control (age) + (1 year) − − + (7 months) + (1 year) + (1 year)
Sitting position (age) + (4 years) − − + (18 months) + (3 years) + (2 years)
Independent walking (age) − − − − − + (3 years)
Poor eye contact + + + + + +
Absent speech + + + + + +
Stereotypic movements + − − + + +
Dysmorphic
features
High and
broad forehead
+ + + + + −
Up slanted
palpebral
fissures
+ + + − − −
S h o r t
prominent
philtrum
+ + − − + −
Small chin + + + + − −
Short nose − + + + − −
Deep set eyes − − − − + +
Large open
mouth
− − − + + −
Additional
dysmorphic
features
Dysplastic ears, Sus-sternal
fistula, Lobulation of the
tongue
− Thin upper lip, clinodactyly of
both 5 fingers, Simian creases,th 
− − −
Epilepsy type/onset Myoclonic, refractory/4
months
Tonicoclonic,
refractory/neonatal
− − Febrile seizure
controlled by
valproate/3 years
Tonicoclonic controlled by
valproate/9 months
MRI
Abnormal
c o r p u s
callosum
− + + − + −
Other brain
MRI anomalies
Fronto parietal atrophy,
Enlarged pericerebral spaces
Enlarged lateral
ventricles, Reduced
cortical gyration
Verticalisation of the tent of the
cerebellum, Enlarged 4th 
ventricle
Enlarged 4 ventricleth − Enlarged lateral ventricles,
Periventricular white-matter
hyperintensities
Periventricular
heterotopia
− − − − − −
Additional feaures Oedema of hands and feet Bilateral 2 3 toe syndactyly,–
Ectopic testis
Left 2 3 toe syndactyly, Right–
distal phalange Agenesis of toes
2 5–
Episodic
hyperventilation and
apnea
Feeding difficulties
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OFC, occipitofrontal circumference; SD, standard deviation; MRI, magnetic resonance imaging; EEG, electroencephalogram
